Contribution of the -173 G/C Polymorphism of Macrophage Migration Inhibitory Factor Gene to the Risk of Inflammatory Bowel Diseases

• Authors: Karolina Przybyłowska , Jerzy Mrowicki , Andrzej Sygut , Piotr Narbutt , Łukasz Dziki , Adam Dziki , Ireneusz Majsterek
• Languages of publication: EN

Abstracts

EN

Inflammatory bowel disease (IBD) represents a heterogeneous group of chronic disorders characterized by inflammation of gastrointestinal tract, typically with a relapsing and remitting clinical course of unknown etiology. Presumably, IBD develops with response exogenous environmental factors only in persons with genetic predisposition. This predisposition was suggested to be associated with polymorphism and mutations in genes encoding proinflammatory immune system proteins. Enhanced production of macrophage migration inhibitory factor (MIF) was found in patients with inflammatory bowel disease (IBD) and mice with experimental colitis. These results suggest that MIF plays a critical role in etiology of the colitis.The aim of the study was determine whether the MIF -173 G/C gene polymorphism is associated with the susceptibility to inflammatory bowel disease (IBD).Material and methods. A total of 99 IBD patients, including 58 patients with ulcerative colitis (UC) and 41 with Crohn's disease (CD) and 436 healthy controls recruited from the Polish population, were genotyped for MIF polymorphisms. Genotyping of MIF gene polymorphism was performed by a RFLP-PCR.Results. We found an increased risk of UC for the C allele of the MIF-173 G/C polymorphism. The distribution of the genotypes was not significantly different in the CD group compared with the controls.Conclusions. We demonstrated that the C allele is associated with an increased risk for development of UC. This suggests that the G/C polymorphism in the MIF gene promoter may be a potential risk factor for UC in Polish population.

Keywords

EN

inflammatory bowel disease; MIF -173 G/C gene polymorphism; Crohn's disease

• Publisher: De Gruyter Open
• Journal: Polish Journal of Surgery
• Year: 2011
• Volume: 83
• Issue: 2
• Pages: 76-80

Dates

published

1 - 2 - 2011

online

30 - 3 - 2011

Contributors

author

Karolina Przybyłowska

• Department of Chemistry and Biochemistry, Medical University in Łódź

author

Jerzy Mrowicki

• Department of Chemistry and Biochemistry, Medical University in Łódź

author

Andrzej Sygut

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Piotr Narbutt

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Łukasz Dziki

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Adam Dziki

• Department of General and Colorectal Surgery, Medical University in Łódź

author

Ireneusz Majsterek

• Department of Chemistry and Biochemistry, Medical University in Łódź

References

• Kamińska B, Lewandowski P: Rola wybranych czynników środowiskowych w etiopatogenezie nieswoistych zapaleń jelit. Forum Medycyny Rodzinnej 2009; 3(1): 42-48.
• Matsuura T, West GA, Youngman KR et al.: Immune activation genes in inflammatory bowel disease. Gastroenterology 1993; 104(2): 448-58.[PubMed]
• Pena AS et al.: Genetics and epidemiology may contribute to understanding the pathogenesis of IBD- a new approach is now indicated. Can J Gastroenterol 1993; 7: 71-75.
• Ohkawara T, Nishihira J, Takeda H et al.: Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice. Gastroenterology 2002; 123: 256-70.
• Murakami H, Akbar SMF, Matsui H et al.: Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance. Eur J Clin Invest 2001; 31: 337-43.
• Donn R, Alourfi Z, De Benedetti F et al.: Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthristis. Arthritis Rheum 2002; 46(9): 2402-09.[Crossref]
• Onodera S, Tanji H, Suzuki K et al.: High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 1999; 11: 163-67.
• Donnelly SC, Haslett C, Reid PT et al.: Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 1997; 3: 320-23.[PubMed]
• Lan HY, Yang N, Nikolic-Paterson DJ et al.: Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int 2000; 57: 499-509.
• Miterski B. Drynda S, Böschow G et al.: Complex genetic predisposition in adult and juvenile rheumatoid arthrist. BMC Genet 2004 Feb 4; 5: 2.[Crossref]
• Bucala R: MIF rediscovered: pituitary hormone and glucocorticoid-induced regulator of cytokine production. FASEB J 1996; 7: 19-24.
• Calandra T, Bernhagen J, Metz CN et al.: MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68-71.
• Calandra T, Bernhagen J, Mitchell RA et al.: The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994; 179: 1895-1902.
• de Jong YP, Abadia-Molina AC, Satoskar AR et al.: Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001; 2: 1061-66.[PubMed]
• Renner P, Roger T, Calandra T: Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis 2005; 41 Suppl 7: S513-19[Crossref]
• Fei BY, Lv HX, Yang JM et al.: Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population. Cytokine 2008; 41(1): 44-47.[WoS][PubMed]
• Nohara H, Okayama N, Inoue N et al.: Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis. J Gastroenterol 2004; 39(3): 242-46.
• Shiroeda H, Tahara T, Nakamura M et al.: Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine 2010 Aug; 51(2): 173-77.[Crossref][WoS]
• Dambacher J, Staudinger T, Seiderer J et al.: Macrophage migration inhibitory factor (MIF) - 173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease. Inflamm Bowel Dis. 2007 Jan; 13(1): 71-82.[WoS]

Identifiers

DOI

10.2478/v10035-011-0012-x